Diversified Trust CO 89bio, Inc. Call Options Transaction History
Diversified Trust CO
- $3.55 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ETNB
# of Institutions
207Shares Held
160MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$207 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$201 Million3.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.3MShares$145 Million4.56% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$94.4 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$72.6 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $471M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...